Tag Archives: Biotech

Dyne Therapeutics COO sells over $300,000 in company stock, a move that has sent ripples through the financial world and sparked questions about the company’s future. This significant transaction, occurring amidst a complex market landscape, invites scrutiny and raises concerns about the potential impact on investor confidence and the company’s …

Avidity Biosciences director sells shares worth over $228k, sparking curiosity among investors and industry watchers alike. This move, by a high-ranking executive of a promising biotech company, raises questions about the company’s future prospects and the director’s own confidence in its trajectory. Avidity Biosciences, known for its innovative approach to …

Cargo Therapeutics CFO Anup Radhakrishnan sells shares worth over $40k, a move that has sparked curiosity and speculation within the financial community. This transaction, while seemingly minor, raises questions about the company’s financial health and potential future prospects. Cargo Therapeutics, a biotech company focused on developing innovative therapies for cancer, …